News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,019 Results
Type
Article (727)
Company Profile (19)
Press Release (12273)
Section
Business (4471)
Career Advice (16)
Deals (652)
Drug Delivery (2)
Drug Development (2331)
Employer Resources (2)
FDA (203)
Job Trends (271)
News (7198)
Policy (376)
Tag
2024 Bio NC Standard (1)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
Academia (37)
Adcomms (3)
Allergies (4)
Alliances (1208)
ALS (1)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (8)
Approvals (201)
Artificial intelligence (3)
Bankruptcy (4)
Best Places to Work (218)
BIOSECURE Act (4)
Biosimilars (1)
Biotechnology (15)
Bladder cancer (1)
Cancer (55)
Cardiovascular disease (6)
Career advice (10)
CAR-T (9)
Cell therapy (27)
Clinical research (1779)
Collaboration (29)
Compensation (15)
COVID-19 (102)
CRISPR (4)
C-suite (9)
Cystic fibrosis (1)
Data (47)
Diabetes (3)
Diagnostics (31)
Drug discovery (1)
Earnings (1400)
Editorial (1)
Employer resources (2)
Events (2383)
Executive appointments (31)
FDA (228)
Featured Employer (2)
Funding (26)
Gene editing (8)
Gene therapy (17)
GLP-1 (17)
Government (43)
Guidances (1)
Healthcare (384)
Immunology and inflammation (1)
Infectious disease (103)
Inflammatory bowel disease (6)
Intellectual property (3)
Interviews (3)
IPO (359)
Job creations (61)
Job search strategy (10)
Kidney cancer (1)
Labor market (2)
Layoffs (12)
Legal (64)
Liver cancer (1)
Lung cancer (6)
Lymphoma (10)
Management (1)
Manufacturing (8)
Medical device (63)
Medtech (63)
Mergers & acquisitions (306)
Metabolic disorders (6)
Neurodegenerative disease (4)
Neuroscience (18)
NextGen: Class of 2025 (138)
Non-profit (19)
Northern California (97)
Now hiring (1)
Obesity (3)
Opinion (1)
Ovarian cancer (1)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (9)
Patient recruitment (3)
People (1673)
Phase I (803)
Phase II (868)
Phase III (523)
Pipeline (28)
Policy (6)
Postmarket research (25)
Preclinical (270)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (112)
Recruiting (1)
Regulatory (315)
Reports (2)
Research institute (62)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (8)
Series B (2)
Service/supplier (1)
Southern California (93)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (103)
Supply chain (1)
United States (603)
Vaccines (11)
Webinars (1)
Weight loss (1)
Date
Today (2)
Last 7 days (9)
Last 30 days (62)
Last 365 days (971)
2025 (235)
2024 (1025)
2023 (1262)
2022 (1594)
2021 (1626)
2020 (1245)
2019 (733)
2018 (541)
2017 (662)
2016 (547)
2015 (593)
2014 (398)
2013 (340)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (14)
Asia (1075)
Australia (89)
California (257)
Canada (70)
China (20)
Colorado (2)
Connecticut (8)
Delaware (5)
Europe (1257)
Florida (17)
Idaho (1)
Illinois (5)
India (1)
Indiana (1)
Japan (2)
Maryland (46)
Massachusetts (112)
Michigan (1)
Minnesota (4)
New Jersey (45)
New Mexico (1)
New York (21)
North Carolina (14)
Northern California (97)
Oklahoma (1)
Pennsylvania (43)
South America (9)
Southern California (93)
Texas (19)
Utah (1)
Washington D.C. (2)
Washington State (9)
Wisconsin (1)
13,019 Results for "vaxil biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
News
Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
August 21, 2024
·
10 min read
Vaxil Provides Update on Research Activities and Management Changes
VAXIL BIO LTD., an innovative immunotherapy biotech company specializing in cancer and infectious diseases announces the follow update on its research activities and changes in senior management.
August 2, 2023
·
5 min read
Press Releases
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
3 min read
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Press Releases
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
March 24, 2025
·
8 min read
Press Releases
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System
March 10, 2025
·
4 min read
Press Releases
Bolt Biotherapeutics to Participate in Upcoming March 2025 Conferences
February 26, 2025
·
1 min read
Press Releases
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
March 5, 2025
·
2 min read
Press Releases
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
March 31, 2025
·
8 min read
1 of 1,302
Next
